Real-world usage pattern, effectiveness and safety of oral tramadol/dexketoprofen trometamol fixed-dose combination in moderate-to-severe acute pain in Asia: a prospective, multicentre, observational study
Authors:
- Kok Yuen HoKHKok Yuen Ho
- Bibek GyanwaliBGBibek Gyanwali
- Cesar DimayugaCDCesar Dimayuga
- Edgar Michael EufemioEEEdgar Michael Eufemio
- Edwin BernardoEBEdwin Bernardo
- Gopinathan RajuGRGopinathan Raju
- Keen Wai ChongKCKeen Wai Chong
- Kritsadakorn WaithayayothinKWKritsadakorn Waithayayothin
- Leonardo OnaLOLeonardo Ona
- Marc Anthony L CastroMCMarc Anthony L Castro
- Passakorn SawaddirukPSPassakorn Sawaddiruk
- Roehl C SalvadorRSRoehl C Salvador
Open Access
Abstract
Objectives This study aims to determine the usage pattern, effectiveness and safety of oral tramadol 75 mg and dexketoprofen trometamol 25 mg fixed-dose combination (TRAM/DKP FDC) in the short-term treatment of moderate-to-severe acute pain in real-world clinical practice in Asia. Design Real-world, prospective, multicentre, observational, phase IV study. Setting 13 tertiary-care hospital sites across the Philippines, Thailand, Malaysia and Singapore. Participants Adult patients aged 18–80 years prescribed TRAM/DKP FDC for the short-term (up to 5 days) treatment of moderate-to-severe acute pain. Main outcome measures Primary endpoints were the proportion of patients prescribed TRAM/DKP FDC with different types of postsurgical and non-surgical treatments, and the average dosing frequency and duration of TRAM/DKP FDC treatment. Secondary endpoints were the proportion of patients achieving ≥30% pain reduction at 8 hours post the first dose (pain severity was assessed using the 11-point Numeric Pain Rating Scale); patient satisfaction at the end of treatment (based on a 5-point Patient Global Evaluation Scale (PGE)) and safety including the incidence of adverse drug reactions (ADRs). Results Among 599 patients (median age 44 years, 61.3% female) enrolled in this study, 68.61% (n=411) were postsurgical and 31.39% (n=188) were non-surgical patients. TRAM/DKP FDC was prescribed in a diverse group of postsurgical patients (eg, orthopaedic, general and cancer surgery) as well as in non-surgical conditions (eg, lower back pain and musculoskeletal pain). In the majority of patients, TRAM/DKP FDC was prescribed every 8 hours (65.94%) and for 5 days (78.80%). There was a significant reduction in pain intensity throughout the study and 65% of patients achieved ≥30% pain reduction from baseline at 8 hours post the first dose of TRAM/DKP FDC on day 1. 95.69% of patients were satisfied with the treatment (rated good, very good and excellent on the PGE scale). Overall, 13.9% of patients reported ADRs; most were mild to moderate in severity. The most common ADRs were nausea, vomiting and dizziness. Conclusion This study showed that TRAM/DKP FDC was used in diverse types of postsurgical and non-surgical patients in the real-world setting in Asia. It effectively reduced pain and was well tolerated with a high level of patient satisfaction.Keywords
Funding Information
- A. Menarini Asia-Pacific Holdings Pte. Ltd., Singapore ((award/grant number-N/A))
This publication has 36 references indexed in Scilit:
- Dexketoprofen Trometamol and Tramadol Hydrochloride Fixed-Dose Combination in Moderate to Severe Acute Low Back Pain: A Phase IV, Randomized, Parallel Group, Placebo, Active-Controlled Study (DANTE)Pain and Therapy, 2024
- A Randomized Control Trial of Dexketoprofen/Vitamin B (Thiamine, Pyridoxine and Cyanocobalamin) Fixed-Dose Combination in Post-Traumatic Grade I–II Cervical SprainsClinical Drug Investigation, 2024
- Efficacy and tolerability of orally administered tramadol/dexketoprofen fixed-dose combination compared to diclofenac/thiocolchicoside in acute low back pain: experience from an Italian, single-centre, observational studyCurrent Medical Research and Opinion, 2020
- A review of dexketoprofen trometamol in acute painCurrent Medical Research and Opinion, 2018
- Multimodal analgesia in moderate-to-severe pain: a role for a new fixed combination of dexketoprofen and tramadolCurrent Medical Research and Opinion, 2017
- Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative CouncilThe Journal of Pain, 2016
- The Determination and Application of Fixed-Dose Analgesic Combinations for Treating Multimodal PainThe Journal of Pain, 2010
- What decline in pain intensity is meaningful to patients with acute pain?Pain, 2003
- Opioid and non-opioid analgesicsBest Practice & Research Clinical Anaesthesiology, 2003
- Pain: an overviewThe Lancet, 1999